Binding affinity does not equal potency for anti androgens? Comparing pyrilutimide to cb-03-01
    Research/Science 10/9/2022

    At a glance
    In this general discussion post, the primary subjects mentioned are
    πŸ’§ pyrilutamide (topical) 0.5% once daily 1 week
    πŸ’§ RU58841 (topical)
    πŸ’§ CB-03-01 (topical) 1 month
    the tone is 😐 neutral.

    Other terms

    Pyrilutimide and CB-03-01, two treatments for hair loss, have similar clinical trial results despite different binding affinities to androgen receptors. Factors other than binding affinity, like the time a drug stays bound to the receptor, may influence their effectiveness.
    View this post in the Community β†’

    Similar Community Posts Join

    5 / 748 results

      community PYRILUTAMIDE KX-826 experience

      in Research/Science  95 upvotes 2 years ago
      A user's experience with the hair loss treatment Pyrilutamide KX-826, which has resulted in some side effects and shedding. The conversation also includes advice for baseline pictures and trying treatments for at least 6 months.

      community KX-826 Pyrilutamide1% coming soon

      in Update  152 upvotes 3 months ago
      KX-826 Pyrilutamide 1% is launching soon, and users are discussing its potential benefits and drawbacks compared to other treatments like Minoxidil and finasteride. Some users are skeptical about its effectiveness, while others are hopeful it will be a safer alternative.

      community What’s more reliable right now, pyrilutamide or RU?

      in Treatment  15 upvotes 1 year ago
      Treatments for hair loss, with the user considering Pyrilutamide and RU58841 as options. It is noted that although Pyrilutamide has been studied more and is allegedly more effective, there are doubts about its authenticity in the market. KX-826 is suggested as an alternative as it has a stronger effect than RU58841 and there is scientific research on it.

    Related Research

    6 / 7 results